Welcome to Paid Research Studies




  • Condition:   Prostate Cancer
    Intervention:   Drug: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Condition:   Lung Cancer
    Interventions:   Drug: (99m Tc) ECDG (Ethylenedicysteine-Deoxyglucose);   Drug: 18 F FDG followed by PET/CT imaging
    Sponsor:   Cell>Point LLC
    Recruiting

  • Condition:   Brain Cancer
    Intervention:  
    Sponsor:   University of Utah
    Recruiting

  • Conditions:   EGFR Gene Amplification;   EGFR Gene Mutation;   Glioblastoma;   Recurrent Glioblastoma;   Supratentorial Glioblastoma;   TP53 wt Allele
    Interventions:   Other: Fludeoxyglucose F-18;   Drug: Osimertinib;   Procedure: Positron Emission Tomography
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI);   Translational Research in Oncology;   AstraZeneca
    Recruiting

  • Conditions:   Metastatic Head and Neck Squamous Cell Carcinoma;   Metastatic Malignant Neoplasm in the Uterine Cervix;   Positive Lymph Node
    Interventions:   Procedure: Computed Tomography;   Other: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Lung Carcinoma;   Solitary Pulmonary Nodule;   Cigarette Smoking Behavior
    Interventions:   Procedure: Computed Tomography;   Radiation: fluorodeoxyglucose F-18;   Drug: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography (PET)
    Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Glioblastoma
    Interventions:   Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography
    Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Cigarette Smoker;   Current Smoker;   Former Smoker;   Multiple Pulmonary Nodules;   Pulmonary Nodule
    Interventions:   Procedure: Computed Tomography;   Drug: Fludeoxyglucose F-18;   Drug: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Procedure: Positron Emission Tomography
    Sponsors:   Andrei Iagaru;   Canary Foundation;   Boston University
    Recruiting

  • Conditions:   Breast Carcinoma;   Fallopian Tube Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Solid Neoplasm
    Interventions:   Procedure: Computed Tomography;   Drug: Fludeoxyglucose F-18;   Drug: Fluorine F 18 Fluorthanatrace;   Procedure: Positron Emission Tomography
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Breast Adenocarcinoma;   Recurrent Breast Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Mycosis Fungoides;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Hodgkin Lymphoma;   Refractory Mycosis Fungoides;   Refractory Nodal Marginal Zone Lymphoma;   Refractory Non-Hodgkin Lymphoma;   Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;   Stage IV Breast Cancer AJCC v6 and v7
    Interventions:   Drug: Belinostat;   Drug: Carfilzomib;   Biological: Daratumumab;   Drug: Fludeoxyglucose F-18;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Obinutuzumab;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Biological: Rituximab;   Drug: Romidepsin;   Other: Saline;   Biological: Trastuzumab
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Stage IIB Non-Small Cell Lung Carcinoma AJCC v7;   Stage IIIA Non-Small Cell Lung Cancer AJCC v7;   Stage IIIB Non-Small Cell Lung Cancer AJCC v7
    Interventions:   Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Radiation: Radiation Therapy;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Radiation: Technetium Tc-99m Sulfur Colloid
    Sponsors:   University of Washington;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cervical Undifferentiated Carcinoma;   Recurrent Cervical Carcinoma;   Stage IB2 Cervical Cancer;   Stage II Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
    Interventions:   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Procedure: Positron Emission Tomography
    Sponsors:   University of Washington;   National Cancer Institute (NCI)
    Recruiting